| Medicated groups | Vaccinated groups | P value | ||||||
---|---|---|---|---|---|---|---|---|---|
Met2 concentrations: | 0.45% | 0.56% | 0.68% | 0.45% | 0.56% | 0.68% | Anticoccidial program | Met levels | Anticoccidial program × Met levels |
CD4 (%) | 9.72 ± 1.05c | 12.27 ± 1.36a | 12.12 ± 1.33a | 12.95 ± 1.42a | 10.85 ± 1.27b | 10.61 ± 1.17bc | 0.092 | 0.028 | 0.002 |
CD8 (%) | 8.51 ± 0.92d | 11.16 ± 1.23a | 10.96 ± 1.08ab | 10.24 ± 1.14b | 9.51 ± 1.03bc | 9.21 ± 0.99c | 0.045 | 0.015 | 0.005 |
CD4/CD8 | 1.15 ± 0.11b | 1.10 ± 0.11b | 1.11 ± 0.13b | 1.27 ± 0.12a | 1.14 ± 0.12b | 1.16 ± 0.13b | 0.023 | 0.041 | 0.003 |
sIgA (mg/mL) | 1.30 ± 0.19b | 1.47 ± 0.22a | 1.52 ± 0.27a | 1.50 ± 0.24a | 1.49 ± 0.21a | 1.50 ± 0.28a | 0.028 | 0.037 | 0.008 |
TNF-α | 1.09 ± 0.11b | 1.39 ± 0.20a | 1.47 ± 0.26a | 0.83 ± 0.09c | 0.87 ± 0.10c | 0.81 ± 0.07c | 0.008 | 0.035 | 0.025 |
IL-2 | 1.04 ± 0.09b | 1.27 ± 0.14a | 1.23 ± 0.18a | 0.97 ± 0.11b | 0.95 ± 0.09b | 0.98 ± 0.07b | 0.013 | 0.039 | 0.031 |
IFN-γ | 1.10 ± 0.14e | 1.54 ± 0.25c | 1.62 ± 0.29b | 1.76 ± 0.33a | 1.33 ± 0.22d | 1.14 ± 0.13e | 0.074 | 0.005 | 0.001 |